drugset
Drugs / exosomes derived from human umbilical cord blood mesenchymal stem cells
last change May 2026 re-read 3 minutes ago

exosomes derived from human umbilical cord blood mesenchymal stem cells

Other / unclassified

Developed for
amyotrophic lateral sclerosis
Investigated by
Shengqi Medical Technology (Guangzhou) Co., Ltd. · Viyun (Xiamen) Biomedical Research Institute Co., Ltd. · Xuanwu Hospital, Beijing

Trials 1

today NCT06598202 · Ph 1/2
20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT06598202 Dec 2024 → May 2026 overdue amyotrophic lateral sclerosis Xuanwu Hospital, Beijing Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as exosomes derived from human umbilical cord blood mesenchymal stem cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT06598202 ↗
Modality Other / unclassified “small extracellular vesicles” NCT06598202 ↗
Route Intranasal “as a nasal drop” NCT06598202 ↗